Opendata, web and dolomites

SQUALAC

Preclinical development of squalenic acid and gemcitabine squalene nanomedicine

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SQUALAC project word cloud

Explore the words cloud of the SQUALAC project. It provides you a very rough idea of what is the project "SQUALAC" about.

drugs    confers    nanoparticles    gem    squalenoylation    natural    pharmaceutical    incidentally    nanomedicines    candidate    disease    shark    acid    regulatory    chemistry    course    goals    laquo    excessive    loading    clinical    template    therapy    treatment    sq    van    remarkably    innovation    nanomedicine    total    gemcitabine    property    hunting    pancreatic    bioconjugate    parent    triggered    erc    perform    tamelen    never    remarkable    sqco2h    green    environmental    ternanomed    employed    assemble    compound    shown    acceptable    clinic    toxic    release    cro3    spacer    moiety    tumors    devastating    tumor    bioconjugates    platform    linkage    lock    squalenic    poor    anticancer    conformation    impressive    self    raquo    drug    economical    discovered    lipid    itself    translation    experimental    construct    first    cosmetics    squalene    data    molecular    cancer    excipient    folded    resistance    preparation    reaction    grant    chemical    overcome    yield    efficient    deserve    ing    display    synthesis   

Project "SQUALAC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE PARIS-SUD 

Organization address
address: RUE GEORGES CLEMENCEAU 15
city: ORSAY CEDEX
postcode: 91405
website: www.u-psud.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2016-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE PARIS-SUD FR (ORSAY CEDEX) coordinator 150˙000.00

Map

 Project objective

'In the course of the ERC Advanced Grant TERNANOMED, we have discovered that the linkage of squalene (a natural lipid) to many drugs, confers to the resulting bioconjugates the remarkable property to self-assemble as nanoparticles, due to the folded molecular conformation of squalene. This approach is unique and has never been used before. The so called 'squalenoylation' technology may be considered as a generic platform to construct nanomedicines with high drug loading and targeted drug release triggered by the spacer between the drug and the squalene moiety. Remarkably, it was shown that these nanomedicines were more efficient and less toxic than the parent drugs. The gemcitabine-squalene (Gem-SQ) nanomedicine, our first candidate for further pharmaceutical developments, was shown not only to display an impressive anticancer activity in experimental tumors but also to overcome drug resistance, thus addressing a major challenge in tumor therapy. These pre-clinical data deserve further development towards translation into the clinic for the treatment of the pancreatic cancer, a devastating disease. However, the squalenic acid (SQCO2H), the chemical template essential for the synthesis of the Gem-SQ bioconjugate, is currently obtained through the Van Tamelen reaction which cannot be employed for the preparation of a clinical sample of Gem-SQ, because of the use of CrO3 (a toxic compound) and the poor yield of the reaction. Therefore, the synthesis of SQCO2H represents a lock for further clinical development of our Gem-SQ nanomedicine. The goals of the present proposal are : (i) to perform the total synthesis of SQCO2H through a new « green » chemistry way (which represents in itself a real innovation) allowing (ii) further regulatory acceptable preparation of Gem-SQ nanoparticles. Incidentally, the total synthesis of SQCO2H will avoid environmental concern due to excessive shark hunting and represents by itself some economical value as excipient for the cosmetics.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SQUALAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SQUALAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ERC VP CSA (2018)

Support to the Vice-Presidents of the ERC Scientific Council 2018

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

CELPRED (2020)

Circuit elements of the cortical circuit for predictive processing

Read More